Abstract: A ladder bracket for hanging a ladder in a trench box is disclosed. The bracket includes a frame, a first arm and a second arm, and a lip. The first arm and second arm each have a first end attached to the frame and a second end extending in a direction away from the frame. The lip is attached to the second end of the first arm and to the second end of the second arm. A distance between the frame and the lip accommodates the bracket being removably hung from a top edge of the trench box. A method of use is also disclosed.

Abstract: A semi-frameless cabinet system including a top panel, bottom panel, two side panels, and a back panel. The cabinet may also include one or more middle shelves, drawers, or doors. Each of the forward facing sides of the cabinet include a grooved surface, wherein edging is secured to each panels such that the panels and edging form an interior space within the cabinet. The edging overlaps the outer edge of the cabinet panels, but not the inner edge, such that the edging and panels are flush within the interior space of the cabinet. As such, the cabinet employs the advantages of both framed and frameless cabinetry.

Abstract: A bed frame for supporting a mattress includes at least first and second sections connectable to form a mattress supporting platform. The platform includes a latch to hold the first and second sections together. The latch includes engageable parts on the first and second sections that are engageable in response to relative sliding movement between the first and second sections toward each other when oriented horizontally.

Abstract: Diagnostic tests for characterizing an individual's risk of developing or having a cardiovascular disease. In one embodiment the present diagnostic test comprises determining the level of myeloperoxidase (MPO) activity in a bodily sample obtained from the individual or test subject. In another embodiment, the diagnostic test comprises determining the level of MPO mass in a bodily sample obtained from the test subject. In another embodiment, the diagnostic test comprises determining the level of one or more select MPO-generated oxidation products in a bodily sample obtained from the test subject. The select MPO-generated oxidation products are dityrosine, nitrotyrosine, methionine sulphoxide or an MPO-generated lipid peroxidation products.

Abstract: Methods for altering levels in plants of one or more phenolic compounds that are intermediates or final products of the plant phenylpropanoid pathway are provided. One method comprises transforming a plant cell with an expression construct comprising a nucleic acid which encodes a transactivator protein comprising the myb domain of the maize “ZmMyb-IF35” protein and an activation domain. Another method comprises transforming a plant cell with an expression construct comprising a transgene which encodes an antisense ZmMyb-IF35 RNA. The present invention also relates to expression constructs and vectors used in the present methods. transformed plant cells and transgenic plants prepared according to the present methods, and the seeds of such transgenic plants.

Abstract: A system and method for diagnosing an electronic device remotely using a network is provided. The electronic device includes one or more programmable logic devices that are configurable. A diagnostic microcontroller functions to communicate to the programmable logic devices and to communicate to the network. To diagnose the electronic device, communication is established to the network and to a diagnostic/repair center. The diagnostic/repair center selects diagnostic commands and transmits them to the electronic device. The diagnostic microcontroller initiates the diagnostic commands on the one or more programmable logic devices to test their configuration and/or functionality. Test results are collected and transmitted back to the diagnostic/repair center for analysis. Based on the analysis, if appropriate, reconfiguration commands are sent to reconfigure the programmable logic device to correct identified errors.

Abstract: A method of non-intrusive, inductive proximity sensing of a target through a conductive barrier comprises the steps of: disposing an inductive proximity sensor on one side of a barrier of conductive material; disposing a target on the other side of the barrier; determining an appropriate drive frequency for operating the proximity sensor based on the conductive material and thickness of the barrier; and operating the proximity sensor with the appropriate drive frequency to non-intrusively sense the proximity of the target through the conductive barrier.

Abstract: High localized loading, galling, and high torque forces have been generally eliminated or greatly reduced in a two ferrule tube fitting assembly through suitable modification of the rear ferrule so as to redirect the reaction forces acting between the front ferrule and the drive nut. The rear ferrule has a cylindrical interior wall that closely surrounds the tube end and is provided on the interior cylindrical wall with a circumferentially continuous radial recess that is located between the nose and rear wall of the rear ferrule. The rear ferrule also has a radially external wall that is substantially conical and additionally shaped to extend radially outward toward the enlarged diameter portion or flange of the rear ferrule. The rear ferrule further includes a contoured face on the rear driven surface of the ferrule that engages the drive surface of the drive nut.

Abstract: Diagnostic tools for for serodiagnosing ehrlichiosis in mammals, particularly in members of the Canidae family and in humans are provided. The diagnostic tools are a group of outer membrane proteins of E. chaffeensis and variants thereof, referred to hereinafter as the “OMP proteins”, a group of outer membrane proteins of E. canis and variants thereof referred to hereinafter as the “P30F proteins”, and antibodies to the OMP proteins and the P30F proteins. The OMP proteins of E. chaffeensis encompass OMP-1, OMP-1A, OMP1-B, OMP-1C, OMP1-D, OMP1-E, OMP1-F, OMP1-H, OMP-1R, OMP-1S, OMP-1T, OMP-1U, OMP-1V, OMP-1W, OMP-1X, OMP-1Y and OMP-1Z. The P30F proteins of E. canis encompass P30, P30a, P30-1, P30-2, P30-3, P30-4, P30-5, P30-6, P30-7, P30-8, P30-9, P30-10, P30-11, and P30-12. Isolated polynucleotides that encode the E. chaffeensis OMP proteins and isolated polynucleotides that encode the E. canis P30F protein are also provided.

Abstract: A toilet cleaning apparatus and caddy is provided which includes a tool which may be held in a user's hand. A swab, which is flushable down the toilet after the cleaning process is complete, is provided which is easily attached and detached from the tool. The tool is movable to a number of operative positions which assist in the loading, holding, or removal of the swab. A caddy is also provided which can hold the tool as well as unused swabs.

Abstract: A modified human prolactin molecule wherein the prolactin molecule comprises at least one mutation in a region selected from i) amino acids 41–57, ii) amino acids 94–110, and iii) amino acids 160–173; and wherein the at least one mutation is selected from deletions, replacements, and insertions. The modified prolactins are prolactin antagonists, and can be used in treating cancer, among other conditions.

Abstract: A web for the manufacture of fluid filled units with a novel machine and process is disclosed. The web includes an elongate heat sealable, flattened plastic tube comprised of face and back imperforate layers. The layers are imperforately joined together along spaced side edges. The layers include superposed longitudinal lines of weakness disposed generally transversely midway between the side edges. The web has longitudinally spaced, pairs of transverse seals. Each transverse seal extends from a respective side edge to an end near but spaced from the longitudinal lines of weakness. The transverse seal pairs include transverse lines of weakness extending from one side edge to the other generally centrally of each seal in a longitudinal direction. The side edges, transverse seals and lines of weakness together delineating two oppositely oriented strings of pouches with each pouch having three imperforate sides and a centrally located fill opening at its fourth side.

Abstract: The present invention provides methods for determining the methylation status of CpG-containing dinucleotides on a genome-wide scale using infrequent cleaving, methylation sensitive restriction endonucleases and two-dimensional gel electrophoretic display of the resulting DNA fragments. Such methods can be used to diagnose cancer, classify tumors and provide prognoses for cancer patients. The present invention also provides isolated polynucleotides and oligonucleotides comprising CpG dinucleotides that are differentially methylated in malignant cells as compared to normal, non-malignant cells. Such polynucleotides and oligonucleotides are useful for diagnosis of cancer. The present invention also provides methods for identifying new DNA clones within a library that contain specific CpG dinucleotides that are differentially methylated in cancer cells as compared to normal cells.